BIO-TECHNE Corp Business Combination, Contingent Consideration, Liability, Current
BIO-TECHNE Corp (TECH) had Business Combination, Contingent Consideration, Liability, Current of $0 as of 2024-03-31, per its 10-Q filed 2024-05-06.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:BusinessCombinationContingentConsiderationLiabilityCurrent · last filed 2024-08-22
- 2024-03-31: Business Combination, Contingent Consideration, Liability, Current $0.00.
- 2023-09-30: Business Combination, Contingent Consideration, Liability, Current $1.75M.
- 2023-06-30: Business Combination, Contingent Consideration, Liability, Current $3.50M.
- 2023-03-31: Business Combination, Contingent Consideration, Liability, Current $5.25M.
| Period end | Business Combination, Contingent Consideration, Liability, Current |
|---|---|
| 2024-03-31 | $0.00 10-Q · filed 2024-05-06 |
| 2023-09-30 | $1.75M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $3.50M 10-K · filed 2024-08-22 |
| 2023-03-31 | $5.25M 10-Q · filed 2023-05-08 |
| 2022-09-30 | $7.40M 10-Q · filed 2022-11-07 |
| 2021-12-31 | $2.00M 10-Q · filed 2022-02-07 |
| 2021-09-30 | $5.00M 10-Q · filed 2021-11-08 |
| 2021-06-30 | $4.00M 10-K · filed 2022-08-24 |
| 2021-03-31 | $5.07M 10-Q · filed 2021-05-07 |
| 2020-12-31 | $4.98M 10-Q · filed 2021-02-08 |
| 2020-09-30 | $5.79M 10-Q · filed 2020-11-09 |
| 2020-06-30 | $5.94M 10-K · filed 2021-08-25 |
| 2020-03-31 | $6.15M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $9.87M 10-Q · filed 2020-02-06 |
| 2019-09-30 | $8.17M 10-Q · filed 2019-11-06 |
| 2019-06-30 | $3.40M 10-K · filed 2020-08-26 |
| 2019-03-31 | $3.40M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $12.50M 10-Q · filed 2019-02-07 |
| 2018-03-31 | $3.50M 10-Q · filed 2018-05-09 |
| 2017-12-31 | $53.30M 10-Q · filed 2018-02-08 |
| 2017-09-30 | $40.90M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $65.10M 10-K · filed 2018-08-27 |
| 2017-03-31 | $67.28M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $63.50M 10-Q · filed 2017-02-09 |
| 2016-09-30 | $49.90M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $0.00 10-Q · filed 2016-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |